These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6280602)

  • 1. Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
    Bayer AS; Morrison JO; Kim KS
    Antimicrob Agents Chemother; 1982 Feb; 21(2):344-6. PubMed ID: 6280602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
    Landesman SH; Corrado ML; Cherubin CE; Sierra MF
    Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.
    Weinstein MP
    Antimicrob Agents Chemother; 1986 Jul; 30(1):187-8. PubMed ID: 3752979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of group B streptococci to cloxacillin, methicillin and cefamandole.
    Dan M; Marien GJ; Sand C
    J Antimicrob Chemother; 1983 Jan; 11(1):93. PubMed ID: 6337989
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
    Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
    Rosina M; Mauri J; Germiniani R; Mastropasqua E; Figini G
    Minerva Chir; 1986 Aug; 41(15-16):1347-51. PubMed ID: 3774182
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental group B streptococcal endocarditis treated with penicillin G versus ceftizoxime. In vitro-in vivo disparity.
    Bayer AS; Morrison JO; Kim KS
    Chemotherapy; 1983; 29(5):352-61. PubMed ID: 6311493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro experience with cefonicid.
    Actor P
    Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G.
    Korting HC; Behrendt H; Roth KH; Neubert U
    Chemotherapy; 1984; 30(6):366-72. PubMed ID: 6097409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftizoxime (FK 749) in vitro antibacterial activity.
    Husson MO; Courcol R; Izard D; Leclerc H
    Infection; 1984; 12(1):40-5. PubMed ID: 6323320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G.
    Korting HC; Walther D; Riethmüller U; Meurer M
    Chemotherapy; 1986; 32(4):352-5. PubMed ID: 3525025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
    Tartaglione TA; Polk RE
    Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
    Arai T
    Jpn J Antibiot; 1986 May; 39(5):1237-40. PubMed ID: 3463774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various pharmacological and clinical aspects of 1st-, 2d- and 3d-generation cephalosporins (I)].
    Barucchi AM; Mazza A; Pesce A; Viti M
    Parodontol Stomatol (Nuova); 1985; 24(1):119-31. PubMed ID: 3937980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.